In this model, in vitro murine alloantigen-induced Tregs pre-treated with AA showed more stable Foxp3 expression when transferred into mice with acute GVHD and were clinically effective to diminish GVHD symptoms. The gene discussed is FOXP3; the disease is graft versus host disease.